BEGESAND Trademark

Trademark Overview


On Thursday, September 8, 2016, a trademark application was filed for BEGESAND with the United States Patent and Trademark Office. The USPTO has given the BEGESAND trademark a serial number of 79201532. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 26, 2024. This trademark is owned by ADIENNE SA. The BEGESAND trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; medical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; and veterinary preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, and substances in the nature of beverages for medical or veterinary use; monoclonal antibodies and antibody mixtures for medi...

Surgical, medical, dental and veterinary apparatus and instruments, namely, infusion bag, vial, syringe; needles for medical use, medical apparatus and instruments, containers for applying medicines, namely, infusion bag, vial, syringe, hypodermic syringes, syringes for medical use, pumps for medical use, namely, infusion pump
begesand

General Information


Serial Number79201532
Word MarkBEGESAND
Filing DateThursday, September 8, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 26, 2024
Registration Number5372122
Registration DateTuesday, January 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; medical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; and veterinary preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, and substances in the nature of beverages for medical or veterinary use; monoclonal antibodies and antibody mixtures for medical use, namely, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; monoclonal antibodies for immunomodulatory treatments, in particular for the treatment of diseases mediated by the differentiation cluster 26 molecule CD26; pharmaceutical preparations comprising as active ingredient monoclonal antibodies having immunomodulatory effects, in particular for the treatment of diseases mediated by the 26 differentiation cluster molecule CD26; dietetic foods, namely, yogurt and rice-derived products, namely, rice flour adapted for medical use, dietetic beverages adapted for medical use, food supplements, enzyme food supplements, protein food supplements, protein supplements for animals, by-products of the processing of cereals for dietetic or medical use, biological preparations for medical use, biological preparations for veterinary use, pills for medicines, namely, immunosuppressant pills, chemical preparations for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, chemical preparations for veterinary use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, biological tissue cultures for medical use, biological tissue cultures for veterinary use, enzyme preparations for medical use, enzyme preparations for veterinary use, enzymes for medical use, enzymes for veterinary use, medicines for veterinary use for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for veterinary use, namely, monoclonal antibodies for immunomodulatory treatments, vaccines, veterinary products in the nature of anti-infective products for veterinary use; living tissue grafts, surgical implants composed of living tissue, radiological contrast substances for medical use, diagnostic preparations for medical use, biomarker reagents for diagnosis for medical use, adjuvants for medical use, chemical preparations for pharmaceutical use, drugs for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations, namely, elixirs for treating viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, plant extracts for pharmaceutical use, medicinal infusions for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, lotions for pharmaceutical use, medicines or human medicine for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for human medicine in the nature of solution for injection for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, syrups for pharmaceutical use for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders
Goods and ServicesSurgical, medical, dental and veterinary apparatus and instruments, namely, infusion bag, vial, syringe; needles for medical use, medical apparatus and instruments, containers for applying medicines, namely, infusion bag, vial, syringe, hypodermic syringes, syringes for medical use, pumps for medical use, namely, infusion pump

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 26, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADIENNE SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameADIENNE SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameADIENNE SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, February 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 16, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, February 25, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2017ASSIGNED TO EXAMINER
Tuesday, February 21, 2017APPLICATION FILING RECEIPT MAILED
Friday, February 24, 2017NON-FINAL ACTION WRITTEN
Tuesday, February 28, 2017REFUSAL PROCESSED BY MPU
Tuesday, February 28, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 18, 2017REFUSAL PROCESSED BY IB
Monday, July 24, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 29, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 4, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018REGISTERED-PRINCIPAL REGISTER
Monday, April 9, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, April 16, 2018FINAL DISPOSITION PROCESSED
Wednesday, August 23, 2017ASSIGNED TO LIE
Tuesday, September 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 4, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Saturday, October 21, 2017NOTIFICATION PROCESSED BY IB
Monday, April 16, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, January 9, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 26, 2024CANCELLED SECTION 71
Friday, December 31, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 1, 2018FINAL DECISION TRANSACTION PROCESSED BY IB